HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis
- PMID: 25904369
- PMCID: PMC4607734
- DOI: 10.1093/cid/civ325
HIV Infection Is Associated With Progression of Subclinical Carotid Atherosclerosis
Abstract
Background: Individuals infected with human immunodeficiency virus (HIV) live longer as a result of effective treatment, but long-term consequences of infection, treatment, and immunological dysfunction are poorly understood.
Methods: We prospectively examined 1011 women (74% HIV-infected) in the Women's Interagency HIV Study and 811 men (65% HIV-infected) in the Multicenter AIDS Cohort Study who underwent repeated B-mode carotid artery ultrasound imaging in 2004-2013. Outcomes included changes in right common carotid artery intima-media thickness (CCA-IMT) and new focal carotid artery plaque formation (IMT >1.5 mm) over median 7 years. We assessed the association between HIV serostatus and progression of subclinical atherosclerosis, adjusting for demographic, behavioral, and cardiometabolic risk factors.
Results: Unadjusted mean CCA-IMT increased (725 to 752 µm in women, 757 to 790 µm in men), but CCA-IMT progression did not differ by HIV serostatus, either in combined or sex-specific analyses. Focal plaque prevalence increased from 8% to 15% in women and 25% to 34% in men over 7 years. HIV-infected individuals had 1.6-fold greater risk of new plaque formation compared with HIV-uninfected individuals (relative risk [RR] 1.61, 95% CI, 1.12-2.32), adjusting for cardiometabolic factors; the association was similar by sex. Increased plaque occurred even among persistently virologically suppressed HIV-infected individuals compared with uninfected individuals (RR 1.56, 95% CI, 1.07-2.27). HIV-infected individuals with baseline CD4+ ≥ 500 cells/µL had plaque risk not statistically different from uninfected individuals.
Conclusions: HIV infection is associated with greater increases in focal plaque among women and men, potentially mediated by factors associated with immunodeficiency or HIV replication at levels below current limits of detection.
Keywords: HIV infection; atherosclerosis; cardiovascular disease; intima-media thickness; viral load.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Figures


Similar articles
-
Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients.HIV Med. 2005 Nov;6(6):380-7. doi: 10.1111/j.1468-1293.2005.00324.x. HIV Med. 2005. PMID: 16268819
-
Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø Study.Stroke. 2007 Nov;38(11):2873-80. doi: 10.1161/STROKEAHA.107.487264. Epub 2007 Sep 27. Stroke. 2007. PMID: 17901390
-
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.Circulation. 2004 Apr 6;109(13):1603-8. doi: 10.1161/01.CIR.0000124480.32233.8A. Epub 2004 Mar 15. Circulation. 2004. PMID: 15023877
-
[Carotid artery disease and human immunodeficiency virus (HIV) infection].Neurologia. 2009 Jun;24(5):318-30. Neurologia. 2009. PMID: 19642035 Review. Spanish.
-
Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?JACC Cardiovasc Imaging. 2014 May;7(5):515-25. doi: 10.1016/j.jcmg.2013.08.019. JACC Cardiovasc Imaging. 2014. PMID: 24831212 Free PMC article. Review.
Cited by
-
Classical monocyte transcriptomes reveal significant anti-inflammatory statin effect in women with chronic HIV.Cardiovasc Res. 2021 Mar 21;117(4):1166-1177. doi: 10.1093/cvr/cvaa188. Cardiovasc Res. 2021. PMID: 32658258 Free PMC article.
-
HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative.Clin Infect Dis. 2016 Jul 15;63(2):249-56. doi: 10.1093/cid/ciw261. Epub 2016 Apr 26. Clin Infect Dis. 2016. PMID: 27118787 Free PMC article.
-
Cardiovascular Implications of Immune Disorders in Women.Circ Res. 2022 Feb 18;130(4):593-610. doi: 10.1161/CIRCRESAHA.121.319877. Epub 2022 Feb 17. Circ Res. 2022. PMID: 35175848 Free PMC article. Review.
-
Elevated Microparticle Tissue Factor Activity Is Associated With Carotid Artery Plaque in HIV-Infected Women.J Acquir Immune Defic Syndr. 2019 May 1;81(1):36-43. doi: 10.1097/QAI.0000000000001988. J Acquir Immune Defic Syndr. 2019. PMID: 30789451 Free PMC article.
-
Prevalence and correlates of carotid plaque in a mixed HIV-serostatus cohort in Uganda.BMC Cardiovasc Disord. 2021 Dec 15;21(1):593. doi: 10.1186/s12872-021-02416-5. BMC Cardiovasc Disord. 2021. PMID: 34911457 Free PMC article.
References
-
- Palella FJ, Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853–60. - PubMed
-
- Wada N, Jacobson LP, Cohen M, French A, Phair J, Munoz A. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984–2008. Am J Epidemiol 2013; 177:116–25. - PMC - PubMed
-
- Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006; 145:397–406. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 AI035042/AI/NIAID NIH HHS/United States
- R01-HL-095140/HL/NHLBI NIH HHS/United States
- U01-AI-034994/AI/NIAID NIH HHS/United States
- U01 AI031834/AI/NIAID NIH HHS/United States
- UL1-TR000004/TR/NCATS NIH HHS/United States
- U01 AI035004/AI/NIAID NIH HHS/United States
- R01-HL-083760/HL/NHLBI NIH HHS/United States
- UL1-TR000454/TR/NCATS NIH HHS/United States
- R01 HL095140/HL/NHLBI NIH HHS/United States
- P30 AI051519/AI/NIAID NIH HHS/United States
- U01-AI-034993/AI/NIAID NIH HHS/United States
- R01-HL-095129/HL/NHLBI NIH HHS/United States
- U01-AI35040/AI/NIAID NIH HHS/United States
- R21 HL120394/HL/NHLBI NIH HHS/United States
- U01 AI034989/AI/NIAID NIH HHS/United States
- R01 HL126543/HL/NHLBI NIH HHS/United States
- R01 HL083760/HL/NHLBI NIH HHS/United States
- U01-AI-035004/AI/NIAID NIH HHS/United States
- U01-AI35042/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- UM1 AI035043/AI/NIAID NIH HHS/United States
- R21-HL-120394/HL/NHLBI NIH HHS/United States
- R01 HL095129/HL/NHLBI NIH HHS/United States
- U01 AI034994/AI/NIAID NIH HHS/United States
- UL1 TR000454/TR/NCATS NIH HHS/United States
- UL1 TR001073/TR/NCATS NIH HHS/United States
- UL1 TR000424/TR/NCATS NIH HHS/United States
- U01-AI35041/AI/NIAID NIH HHS/United States
- U01-AI35039/AI/NIAID NIH HHS/United States
- U01-AI-034989/AI/NIAID NIH HHS/United States
- U01-AI-042590/AI/NIAID NIH HHS/United States
- U01-HD-032632/HD/NICHD NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01 AI034993/AI/NIAID NIH HHS/United States
- UL1-TR000424/TR/NCATS NIH HHS/United States
- P30-AI-051519/AI/NIAID NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- U01-AI-031834/AI/NIAID NIH HHS/United States
- UM1-AI35043/AI/NIAID NIH HHS/United States
- U01 HD032632/HD/NICHD NIH HHS/United States
- U01 AI042590/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials